Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash from Investing Activities: 2013-2024

Historic Cash from Investing Activities for Collegium Pharmaceutical (COLL) over the last 12 years, with Dec 2024 value amounting to -$287.8 million.

  • Collegium Pharmaceutical's Cash from Investing Activities rose 87.60% to -$30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.2 million, marking a year-over-year increase of 81.66%. This contributed to the annual value of -$287.8 million for FY2024, which is 306.37% down from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Cash from Investing Activities is -$287.8 million, which was down 306.37% from -$70.8 million recorded in FY2023.
  • Over the past 5 years, Collegium Pharmaceutical's Cash from Investing Activities peaked at -$1.9 million during FY2021, and registered a low of -$573.7 million during FY2022.
  • For the 3-year period, Collegium Pharmaceutical's Cash from Investing Activities averaged around -$310.8 million, with its median value being -$287.8 million (2024).
  • In the last 5 years, Collegium Pharmaceutical's Cash from Investing Activities soared by 99.48% in 2021 and then plummeted by 29,410.85% in 2022.
  • Collegium Pharmaceutical's Cash from Investing Activities (Yearly) stood at -$373.8 million in 2020, then skyrocketed by 99.48% to -$1.9 million in 2021, then tumbled by 29,410.85% to -$573.7 million in 2022, then skyrocketed by 87.66% to -$70.8 million in 2023, then crashed by 306.37% to -$287.8 million in 2024.